![Glenn A. Miller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Glenn A. Miller
Direttore/Membro del Consiglio presso BioMarker Strategies LLC
Posizioni attive di Glenn A. Miller
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioMarker Strategies LLC
![]() BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Direttore/Membro del Consiglio | 31/05/2011 | - |
Presidente | 07/10/2011 | 04/10/2012 | |
The Human Genome Organization | Corporate Officer/Principal | - | - |
Storia della carriera di Glenn A. Miller
Precedenti posizioni note di Glenn A. Miller
Società | Posizione | Inizio | Fine |
---|---|---|---|
MolecularMD Corp.
![]() MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Direttore Tecnico/Scientifico/R&S | 08/08/2013 | - |
Genzyme Analytical Services | Corporate Officer/Principal | - | - |
ASTRAZENECA PLC | Corporate Officer/Principal | 31/05/2011 | - |
Formazione di Glenn A. Miller
The State University of New York | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Regno Unito | 3 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chairman | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Aziende private | 4 |
---|---|
BioMarker Strategies LLC
![]() BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Health Technology |
The Human Genome Organization | |
MolecularMD Corp.
![]() MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Health Services |
Genzyme Analytical Services |
- Borsa valori
- Insiders
- Glenn A. Miller
- Esperienza